Common Bacteria of Gum Disease Linked to Rheumatoid Arthritis
By LabMedica International staff writers Posted on 28 Dec 2016 |
Image: A colony of Aggregatibacter actinomycetemcomitans, showing the characteristic flower-like morphology (Photo courtesy of UCL Eastman Dental Institute).
A bacterium known to cause chronic inflammatory periodontal infections may also triggers the inflammatory “autoimmune” response characteristic of chronic, joint-destroying rheumatoid arthritis (RA).
An estimated 1.5 million people nationwide live with rheumatoid arthritis and current treatments with steroids, immunotherapy drugs, and physical therapy help some by reducing or slowing the crippling and painful joint deformities, but not in all patients. The exploration of alternative treatment options is necessary.
Scientists at the Johns Hopkins University School of Medicine (Baltimore, MD, USA) and their colleagues used mass spectrometry to define the microbial composition and antigenic repertoire of gingival crevicular fluid in patients with periodontal disease and healthy controls. Periodontitis was characterized by the presence of citrullinated autoantigens that are primary immune targets in RA. The team developed a test using the bacterium and pore-forming toxin leukotoxin A (LtxA) to detect antibodies against Aggregatibacter actinomycetemcomitans in blood using 196 samples from a large study of patients with RA.
Periodontitis was characterized by the presence of citrullinated autoantigens that are primary immune targets in RA. The citrullinome in periodontitis mirrored patterns of hypercitrullination observed in the rheumatoid joint, implicating this mucosal site in RA pathogenesis. Proteomic signatures of several microbial species were detected in hypercitrullinated periodontitis samples. Among these, A.actinomycetemcomitans, but not other candidate pathogens, induced hypercitrullination in host neutrophils. They identified LtxA as the molecular mechanism by which A.actinomycetemcomitans triggers dysregulated activation of citrullinating enzymes in neutrophils, mimicking membranolytic pathways that sustain autoantigen citrullination in the RA joint.
These data were similar to patients, with periodontal disease with approximately 60% positivity, but quite different in healthy controls, who only had 11% of people positive for A. actinomycetemcomitans. More strikingly, exposure to A. actinomycetemcomitans was a major determinant in the production of antibodies to citrullinated proteins in patients with genetic susceptibility to RA. Moreover, LtxA induced changes in neutrophil morphology mimicking extracellular trap formation, thereby releasing the hypercitrullinated cargo. Exposure to leukotoxic A. actinomycetemcomitans strains was confirmed in patients with RA and was associated with both anticitrullinated protein antibodies and rheumatoid factor. The study was published on December 14, 2016, in the journal Science Translational Medicine.
Related Links:
Johns Hopkins University School of Medicine
An estimated 1.5 million people nationwide live with rheumatoid arthritis and current treatments with steroids, immunotherapy drugs, and physical therapy help some by reducing or slowing the crippling and painful joint deformities, but not in all patients. The exploration of alternative treatment options is necessary.
Scientists at the Johns Hopkins University School of Medicine (Baltimore, MD, USA) and their colleagues used mass spectrometry to define the microbial composition and antigenic repertoire of gingival crevicular fluid in patients with periodontal disease and healthy controls. Periodontitis was characterized by the presence of citrullinated autoantigens that are primary immune targets in RA. The team developed a test using the bacterium and pore-forming toxin leukotoxin A (LtxA) to detect antibodies against Aggregatibacter actinomycetemcomitans in blood using 196 samples from a large study of patients with RA.
Periodontitis was characterized by the presence of citrullinated autoantigens that are primary immune targets in RA. The citrullinome in periodontitis mirrored patterns of hypercitrullination observed in the rheumatoid joint, implicating this mucosal site in RA pathogenesis. Proteomic signatures of several microbial species were detected in hypercitrullinated periodontitis samples. Among these, A.actinomycetemcomitans, but not other candidate pathogens, induced hypercitrullination in host neutrophils. They identified LtxA as the molecular mechanism by which A.actinomycetemcomitans triggers dysregulated activation of citrullinating enzymes in neutrophils, mimicking membranolytic pathways that sustain autoantigen citrullination in the RA joint.
These data were similar to patients, with periodontal disease with approximately 60% positivity, but quite different in healthy controls, who only had 11% of people positive for A. actinomycetemcomitans. More strikingly, exposure to A. actinomycetemcomitans was a major determinant in the production of antibodies to citrullinated proteins in patients with genetic susceptibility to RA. Moreover, LtxA induced changes in neutrophil morphology mimicking extracellular trap formation, thereby releasing the hypercitrullinated cargo. Exposure to leukotoxic A. actinomycetemcomitans strains was confirmed in patients with RA and was associated with both anticitrullinated protein antibodies and rheumatoid factor. The study was published on December 14, 2016, in the journal Science Translational Medicine.
Related Links:
Johns Hopkins University School of Medicine
Latest Immunology News
- Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies
- AI Tool Precisely Matches Cancer Drugs to Patients Using Information from Each Tumor Cell
- Genetic Testing Combined With Personalized Drug Screening On Tumor Samples to Revolutionize Cancer Treatment
- Testing Method Could Help More Patients Receive Right Cancer Treatment
- Groundbreaking Test Monitors Radiation Therapy Toxicity in Cancer Patients
- State-Of-The Art Techniques to Investigate Immune Response in Deadly Strep A Infections
- Novel Immunoassays Enable Early Diagnosis of Antiphospholipid Syndrome
- New Test Could Predict Immunotherapy Success for Broader Range Of Cancers
- Simple Blood Protein Tests Predict CAR T Outcomes for Lymphoma Patients
- Cell Sorter Chip Technology to Pave Way for Immune Profiling at POC
- Chip Monitors Cancer Cells in Blood Samples to Assess Treatment Effectiveness
- Automated Immunohematology Approaches Can Resolve Transplant Incompatibility
- AI Leverages Tumor Genetics to Predict Patient Response to Chemotherapy
- World’s First Portable, Non-Invasive WBC Monitoring Device to Eliminate Need for Blood Draw
- Predictive T-Cell Test Detects Immune Response to Viruses Even Before Antibodies Form
- Single Blood Draw to Detect Immune Cells Present Months before Flu Infection Can Predict Symptoms